Samsung Pharma receives US$3.8m order for anti-hangover products
By 황유미Published : July 1, 2016 - 10:00
[DISCLOSURE] Samsung Pharmaceutical (001360) has signed a 4.4 billion won (US$3.8 million) contract with PICO Entech to supply anti-hangover products, it announced on July 1. This amounts to 10.44 percent of its recent revenue.